Massachusetts General Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Massachusetts General Hospital sits in the top decile of US sponsors by registered trial count (#4 of 15,751 sponsors by registered trial count).
Massachusetts General Hospital: 2,032 sponsored US clinical trials, 336 recruiting.
Massachusetts General Hospital sponsors 2,032 registered US clinical trials on ClinicalTrials.gov, 336 of them currently recruiting, and 1,284 completed. 240 of these trials are in Phase 3-4 (later-stage) and 515 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 29 trials.
Top-decile sponsor footprint
Massachusetts General Hospital ranks in the top decile of sponsors by registered trial count (#4 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
2,032 total, page 40 of 41
Folate Supplementation in Schizophrenia
NCT00249288
Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)
NCT00181766
Concerta Treatment in Adults With ADHD NOS
NCT00181740
A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder
NCT00126282
Pathogenesis of Chronic Sinusitis in Relationship to Tobacco Smoke Exposure
NCT01179139
Inflammation and the Host Response to Injury (Trauma)
NCT00257231
Prevention of Cigarette Smoking in Attention Deficit Hyperactivity Disorder (ADHD) Youth With Concerta
NCT00181714
Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer
NCT00181688
Internet-Based Cervical Cytology Screening Program
NCT00658190
Defining Central Circuits of Pain
NCT00112333
Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer
NCT00181584
Effectiveness of Pramipexole for Treatment-Resistant Depression
NCT00231959
Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast Cancer
NCT00694577
Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment
NCT00337350
A Prospective Randomized Trial of Static-Progressive Versus Dynamic Splinting for Post-Traumatic Elbow Stiffness
NCT01241916
Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram
NCT00183677
Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate
NCT00302406
Culturally Sensitive Collaborative Treatment for Depressed Chinese Americans
NCT00227929
Effects of Anorexia Nervosa on Bone Mass in Adolescents
NCT00088153
VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia
NCT00505700
A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder
NCT00181571
The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression
NCT00556140
Bone Loss in Women With Anorexia Nervosa
NCT00089843
Study of Lifestyle Modification in HIV Lipodystrophy
NCT00111358
Phase I Study of Sequential Cord Blood Transplants
NCT00299767
Corticosteroid Injection for Common Upper Extremity Problems
NCT00438672
Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy
NCT00095836
Screening Protocol for Children and Adolescents With Attention Deficit Hyperactivity Disorder
NCT00592436
Drug Therapy to Treat Minor Depression
NCT00048815
Risperidone Augmentation in Patients With Schizophrenia
NCT00289861
Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar Disorder
NCT00181779
Motivational Interviewing Compared to Psychoeducation for Smoking Precontemplators With SMI
NCT01982617
Modified Directly Observed Therapy for Improving Antiretroviral Therapy Adherence in People With HIV
NCT00339092
Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy
NCT00121888
Spectroscopy in Children and Adolescents With Bipolar Disorder
NCT00181831
A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder
NCT00181675
A Study of Sertraline to Prevent PTSD
NCT00182078
Secondary Analysis of Gut Hormones and Inflammatory Cytokines in Fasting Subjects
NCT01257841
Study of Home-Based Resistance and Strength Training in HIV-Infected Women
NCT00111332
Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer
NCT00455624
Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
NCT00113646
Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)
NCT00116532
Escitalopram for the Treatment of Self-Injurious Skin Picking
NCT00115011
Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder
NCT00181987
ET 743 (Yondelis) in Men With Advanced Prostate Cancer
NCT00147212
Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma
NCT00105560
The Safety and Efficacy of Recombinant Human Prolactin
NCT00438490
Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder
NCT00181922
Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women
NCT00136032
Study of Sildenafil in Patient With Heart Failure.
NCT00309816
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 226 |
| Phase 2 | 289 |
| Phase 3 | 58 |
| Phase 4 | 182 |
Therapeutic Areas
What is open in the Massachusetts General Hospital pipeline
336 recruiting of 2,032 indexed (17% open); 1,284 completed (63%).
Phase mix: 240 late (III/IV) vs 515 early (I/II) (early-phase heavy).
Top condition: Depression (29 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.